Defining and Measuring Meditation-Related Adverse Effects in Mindfulness-Based Programs
Open accessThe DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Abstract
Research on the adverse effects of mindfulness-based programs (MBPs) has been sparse and hindered by methodological imprecision. The 44-item Meditation Experiences Interview (MedEx-I) was used by an independent assessor to measure meditation-related side effects (MRSEs) following three variants of an 8-week program of mindfulness-based cognitive therapy ( n = 96). Each item was queried for occurrence, causal link to mindfulness meditation practice, duration, valence, and impact on functioning. Eighty-three percent of the MBP sample reported at least one MRSE. Meditation-related adverse effects with negative valences or negative impacts on functioning occurred in 58% and 37% of the sample, respectively. Lasting bad effects occurred in 6% to 14% of the sample and were associated with signs of dysregulated arousal (hyperarousal and dissociation). Meditation practice in MBPs is associated with transient distress and negative impacts at similar rates to other psychological treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Theoretically, individuals with a history of trauma may be more prone to experiencing MRAEs since documented symptoms involve dysregulated arousal (a characteristic of PTSD), dissociative states, and the re-experiencing of traumatic memories [18, 27].”
From Childhood trauma and subclinical PTSD symptoms predict adverse effects and worse outcomes across two mindfulness-based programs for active depression (2025) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The most common MRSE and negative valence MRAE experiences, as reported in detail in Britton, Lindahl [18], were perceptual hypersensitivity, vivid imagery and thoughts, somatosensory changes, traumatic reexperiencing, anxiety and panic, affective lability, and agitation–all forms of nervous system hyperarousal [52].”
From Childhood trauma and subclinical PTSD symptoms predict adverse effects and worse outcomes across two mindfulness-based programs for active depression (2025) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As Britton, Lindahl [18] reports in detail, many of the experiences that were constitutive or predictive of LBEs, such as executive dysfunction, emotional blunting, self-disturbances, time-space distortions, and derealization, are common characteristics of hypoarousal or dissociation.”
From Childhood trauma and subclinical PTSD symptoms predict adverse effects and worse outcomes across two mindfulness-based programs for active depression (2025) · cites this paper as Britton, Lindahl [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There has also been a lack of research on potential negative impacts of mindfulness training on leadership (see Britton et al., 2021 for meditation-related adverse effects; see also Purser, 2018).”
From Altered states of leadership: mindfulness meditation, psychedelic use, and leadership development (2023) · cites this paper as Britton et al., 2021
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“First, there is a lack of evaluation of harm and adverse effects within MBIs140,141 and psychotherapy research broadly142.”
From A common factors perspective on mindfulness-based interventions (2022) · cites this paper as [140]
17 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
The environment and disease: association or causation?
Hill, A. B. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076814562718 · Cited by 7,285
Journal of Consciousness Studies
(2022) · Journal of Consciousness Studies · doi:10.53765/20512201 · Cited by 6,832
Handbook of Parametric and Nonparametric Statistical Procedures
(2004) · Technometrics · doi:10.1198/tech.2004.s209 · Cited by 4,661
The effect of mindfulness based therapy on anxiety and depression: A meta analytic review
Hofmann, S. G., Sawyer, A. T., Witt, A. A., & Oh, D. (2010) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0018555 · Cited by 3,846
Clinical Psychology: Science and Practice
(2021) · Clinical Psychology Science and Practice · doi:10.1111/(issn)1468-2850 · Cited by 3,672
(2001) · Cited by 3,666
Bergin and Garfield's Handbook of Psychotherapy and Behavior Change
Lambert, M. J. (2003) · Cited by 3,383
(1997) · American Psychiatric Press eBooks · Cited by 3,056
Adverse drug reactions: definitions, diagnosis, and management
Edwards, I. R., & Aronson, J. K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02799-9 · Cited by 2,979
Moher, D. (2001) · JAMA · doi:10.1001/jama.285.15.1987 · Cited by 2,545
The Inventory of Depressive Symptomatology (IDS): Psychometric properties
Rush, A. J., Gullion, C. M., Basco, M. R., Jarrett, R. B., & Trivedi, M. H. (1996) · Psychological Medicine · doi:10.1017/s0033291700035558 · Cited by 2,177 · cited 4×
“…aimed at representing the average adult American mindfulness meditator and included individuals with stress, anxiety, and depression who were selfselected (meditation-seeking) and then carefully screened according to standard MBP exclusion criteria (Kuyken et al., 2012; Santorelli et al., 2017).”
BackgroundMethodInfluentialBetter Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement
Ioannidis, J. P. A., Evans, S. J. W., Gøtzsche, P. C., O'Neill, R. T., Altman, D. G., Schulz, K., Moher, D., & for the CONSORT Group* (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00009 · Cited by 1,593
Van Dam, N. T., van Vugt, M. K., Vago, D. R., Schmalzl, L., Saron, C. D., Olendzki, A., Meissner, T., Lazar, S. W., Kerr, C. E., Gorchov, J., et al. (2018) · Perspectives on Psychological Science · doi:10.1177/1745691617709589 · Cited by 1,506
Self-citationMindfulness-Based Cognitive Therapy for Depression: A New Approach to Preventing Relapse
Morgan, D. (2003) · Psychotherapy Research · doi:10.1080/713869628 · Cited by 1,193
Mindfulness-based interventions for psychiatric disorders: A systematic review and meta-analysis
Goldberg, S. B., Tucker, R. P., Greene, P. A., Davidson, R. J., Wampold, B. E., Kearney, D. J., & Simpson, T. L. (2018) · Clinical Psychology Review · doi:10.1016/j.cpr.2017.10.011 · Cited by 1,145 · cited 2×
“…programs (MBPs) have emerged as a promising treatment for a range of conditions with comparable efficacy to established psychological treatments (Goldberg et al., 2018; Hofmann, Sawyer, Witt, & Oh, 2010), very little is known about negative or adverse effects (Baer, Crane, Miller, & Kuyken,…”
BackgroundPsychological Treatments That Cause Harm
Lilienfeld, S. O. (2007) · Perspectives on Psychological Science · doi:10.1111/j.1745-6916.2007.00029.x · Cited by 959
Handbook of Parametric and Nonparametric Statistical Procedures
Sheskin, D. J. (1996) · CRC Press eBooks · doi:10.4324/9780203489536 · Cited by 910
The Lancet Psychiatry Commission on psychological treatments research in tomorrow's science
Holmes, E. A., Ghaderi, A., Harmer, C. J., Ramchandani, P. G., Cuijpers, P., Morrison, A. P., Roiser, J. P., Bockting, C. L. H., O'Connor, R. C., Shafran, R., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30513-8 · Cited by 624
The good-subject effect: investigating participant demand characteristics
Nichols, A. L., & Maner, J. K. (2008) · The Journal of General Psychology · doi:10.3200/genp.135.2.151-166 · Cited by 615 · cited 1×
“…it is well known that research participants and psychotherapy clients are unlikely to spontaneously report negative treatment reactions because of demand characteristics (the desire to please the therapist or researcher) (Horigian, Robbins, Dominguez, Ucha, & Rosa, 2010; Nichols & Maner, 2008).”
BackgroundIs it time for clinicians to routinely track patient outcome? A meta-analysis
Lambert, M. J., Whipple, J. L., Hawkins, E. J., Vermeersch, D. A., Nielsen, S. L., & Smart, D. W. (2003) · Clinical Psychology: Science and Practice · doi:10.1093/clipsy.bpg025 · Cited by 608 · cited 2×
“156) even though less than 10% of deteriorations result in positive treatment response and intervening on deteriorating patients improves treatment outcomes (Lambert et al., 2003).”
BackgroundParsons, C. E., Crane, C., Parsons, L. J., Fjorback, L. O., & Kuyken, W. (2017) · Behaviour Research and Therapy · doi:10.1016/j.brat.2017.05.004 · Cited by 550
A lab test and algorithms for identifying clients at risk for treatment failure
Hannan, C., Lambert, M. J., Harmon, C., Nielsen, S. L., Smart, D. W., Shimokawa, K., & Sutton, S. W. (2005) · Journal of Clinical Psychology · doi:10.1002/jclp.20108 · Cited by 542
Are randomized clinical trials good for us (in the short term)? Evidence for a “trial effect”
Braunholtz, D. A., Edwards, S. J. L., & Lilford, R. J. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00305-x · Cited by 539
Furukawa, T. A., Noma, H., Caldwell, D. M., Honyashiki, M., Shinohara, K., Imai, H., Chen, P., Hunot, V., & Churchill, R. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12275 · Cited by 521 · cited 2×
“Waitlist control participants are prone to nocebo effects and cannot be used to estimate base rates of AEs without treatment (Cuijpers et al., 2018; Freedland et al., 2019; Furukawa et al., 2014; Van Dam & Galante, 2020).”
BackgroundLindahl, J. R., Fisher, N. E., Cooper, D. J., Rosen, R. K., & Britton, W. B. (2017) · PLOS ONE · doi:10.1371/journal.pone.0176239 · Cited by 476 · cited 12×
“While 25% of the VCE sample encountered meditation-related challenges within the first 50 hours or practicing less than 1 hour per day, the majority required more years of practice or more intensive practice such as meditation retreats (Lindahl et al., 2017).”
BackgroundMethodInfluentialSelf-citationHróbjartsson, A., Emanuelsson, F., Skou Thomsen, A. S., Hilden, J., & Brorson, S. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyu115 · Cited by 462
Segal, Z. V., Teasdale, J. D., Williams, J. M., & Gemar, M. C. (2002) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.320 · Cited by 432
Linden, M. (2013) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.1765 · Cited by 397 · cited 6×
“, 2013), they still affect risk-benefit assessment, treatment tolerability, and quality of life and therefore remain clinically relevant (Linden, 2013; Lineberry et al., 2016).”
BackgroundInfluentialAn investigation of self-assessment bias in mental health providers
Walfish, S., McAlister, B., O'Donnell, P., & Lambert, M. J. (2012) · Psychological Reports · doi:10.2466/02.07.17.pr0.110.2.639-644 · Cited by 394
Methods for Causality Assessment of Adverse Drug Reactions: A Systematic Review
Agbabiaka, T. B., Savović, J., & Ernst, E. (2008) · Drug Safety · doi:10.2165/00002018-200831010-00003 · Cited by 366
Epistemic injustice in psychiatry
Crichton, P., Carel, H., & Kidd, I. J. (2017) · BJPsych Bulletin · doi:10.1192/pb.bp.115.050682 · Cited by 348
Weissman, J. S., Schneider, E. C., Weingart, S. N., Epstein, A. M., David-Kasdan, J., Feibelmann, S., Annas, C. L., Ridley, N., Kirle, L., & Gatsonis, C. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-2-200807150-00006 · Cited by 324
Hatfield, D., McCullough, L., Frantz, S. H. B., & Krieger, K. (2010) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.656 · Cited by 321
How would we know if psychotherapy were harmful?
Dimidjian, S., & Hollon, S. D. (2010) · American Psychologist · doi:10.1037/a0017299 · Cited by 314 · cited 7×
“…researchers and providers are reliably biased, recent guidelines recommend patient-based reports elicited by an independent party for identifying sensitive or socially undesirable information such as negative reactions to treatment (Dimidjian & Hollon, 2010; Fowler, 1998; Weissman et al., 2008).”
BackgroundInfluentialDoing no harm in mindfulness-based programs: Conceptual issues and empirical findings
Baer, R., Crane, C., Miller, E., & Kuyken, W. (2019) · Clinical Psychology Review · doi:10.1016/j.cpr.2019.01.001 · Cited by 307 · cited 7×
“This challenges the idea that negative experiences are more likely to occur at higher practice intensities or when intentionally bringing attention toward difficult experiences (Baer et al., 2019).”
BackgroundInfluentialFREWEN, P. A., & LANIUS, R. A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1364.010 · Cited by 306 · cited 1×
“Clinical Implications The majority of MRAEs occurring in this study, particularly those with negative impacts, are consistent with signs of dysregulated arousal; i.e., hyperarousal and dissociation (Frewen & Lanius, 2006; Treleaven, 2018).”
BackgroundArbisi, P. A., & Ben-Porath, Y. S. (1995) · Psychological Assessment · doi:10.1037//1040-3590.7.4.424 · Cited by 305
Prospects for a clinical science of mindfulness-based intervention
Dimidjian, S., & Segal, Z. V. (2015) · American Psychologist · doi:10.1037/a0039589 · Cited by 291 · cited 1×
“Since MBP development skipped this phase, it has been recommended that MBPs be “sent back” to Phases 0–1 to assess potential AEs properly (Dimidjian & Segal, 2015, p. 605).”
BackgroundCan mindfulness be too much of a good thing? The value of a middle way
Britton, W. B. (2019) · Current Opinion in Psychology · doi:10.1016/j.copsyc.2018.12.011 · Cited by 267 · cited 3×
“These results parallel findings from the VCE study, where greater attenuations in senses of self, although not always unpleasant, were associated with a greater impairment in functioning (Lindahl & Britton, 2019).”
BackgroundResultSelf-citationThe GRADE approach and Bradford Hill's criteria for causation
Schünemann, H., Hill, S., Guyatt, G., Akl, E. A., & Ahmed, F. (2011) · Journal of Epidemiology and Community Health · doi:10.1136/jech.2010.119933 · Cited by 262
Adverse events in meditation practices and meditation‐based therapies: a systematic review
Farias, M., Maraldi, E., Wallenkampf, K. C., & Lucchetti, G. (2020) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13225 · Cited by 262 · cited 2×
“…depression, anxiety or panic; re-experiencing of traumatic memories; dissociation; executive dysfunction; headaches or body pain, insomnia and social impairment (Cebolla et al., 2017; Farias et al., 2020; Lindahl, Fisher, Cooper, Rosen, & Britton, 2017; Lomas, Cartwright, Edginton, & Ridge, 2014).”
BackgroundAdverse Events in Randomized Trials: Neglected, Restricted, Distorted, and Silenced
Ioannidis, J. P. A. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.313 · Cited by 243
Hopewell, S., Altman, D. G., Moher, D., & Schulz, K. F. (2008) · Trials · doi:10.1186/1745-6215-9-20 · Cited by 241
Lomas, T., Medina, J. C., Ivtzan, I., Rupprecht, S., Hart, R., & Eiroa-Orosa, F. J. (2017) · European Journal of Work and Organizational Psychology · doi:10.1080/1359432x.2017.1308924 · Cited by 230
Rozental, A., Kottorp, A., Forsström, D., Månsson, K., Boettcher, J., Andersson, G., Furmark, T., & Carlbring, P. (2019) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465819000018 · Cited by 230 · cited 4×
“or worsening symptoms caused by psychotherapy when measured systematically with a questionnaire (42%– 51%; Moritz et al., 2015; Rozental et al., 2019; SchermulyHaupt et al., 2018).”
BackgroundInfluentialA qualitative analysis of experiential challenges associated with meditation practice
Lomas, T., Cartwright, T., Edginton, T., & Ridge, D. (2015) · Mindfulness · doi:10.1007/s12671-014-0329-8 · Cited by 229
Drug safety assessment in clinical trials: methodological challenges and opportunities
Singh, S., & Loke, Y. K. (2012) · Trials · doi:10.1186/1745-6215-13-138 · Cited by 227
Patient experience of negative effects of psychological treatment: results of a national survey
Crawford, M. J., Thana, L., Farquharson, L., Palmer, L., Hancock, E., Bassett, P., Clarke, J., & Parry, G. D. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.162628 · Cited by 225 · cited 4×
“%) have also been reported in psychotherapy (Crawford et al., 2016; Hansen, Lambert, & Forman, 2002; Lambert, 2013).”
BackgroundInfluentialFreedland, K. E., King, A. C., Ambrosius, W. T., Mayo-Wilson, E., Mohr, D. C., Czajkowski, S. M., Thabane, L., Collins, L. M., Rebok, G. W., Treweek, S. P., et al. (2019) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2019.02.011 · Cited by 218
Schlosser, M., Sparby, T., Vörös, S., Jones, R., & Marchant, N. L. (2019) · PLOS ONE · doi:10.1371/journal.pone.0216643 · Cited by 209 · cited 1×
“In meditation studies, single open-ended questions about “unpleasant” or “unwanted” meditation effects have yielded rates of 25% of meditating samples (Cebolla et al., 2017; Schlosser et al., 2019).”
BackgroundUnwanted effects: is there a negative side of meditation? A multicentre survey
Cebolla, A., Demarzo, M., Martins, P., Soler, J., & Garcia-Campayo, J. (2017) · PLOS ONE · doi:10.1371/journal.pone.0183137 · Cited by 192
Chou, R., Aronson, N., Atkins, D., Ismaila, A. S., Santaguida, P., Smith, D. H., Whitlock, E., Wilt, T. J., & Moher, D. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2008.06.007 · Cited by 184
Hinz, A., Ernst, J., Glaesmer, H., Brähler, E., Rauscher, F. G., Petrowski, K., & Kocalevent, R. (2017) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2016.12.017 · Cited by 178
Bent, S., Padula, A., & Avins, A. L. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-4-200602210-00007 · Cited by 177
Jonsson, U., Alaie, I., Parling, T., & Arnberg, F. K. (2014) · Contemporary Clinical Trials · doi:10.1016/j.cct.2014.02.005 · Cited by 175
Johnson, C., Burke, C., Brinkman, S., & Wade, T. (2016) · Behaviour Research and Therapy · doi:10.1016/j.brat.2016.03.002 · Cited by 167 · cited 1×
“In addition, some RCTs have found that average symptom severity significantly worsened in MBP arms compared with control arms (Britton et al., 2010; Johnson et al., 2016; Lomas et al., 2017; Reynolds et al., 2017).”
BackgroundDuggan, C., Parry, G., McMurran, M., Davidson, K., & Dennis, J. (2014) · Trials · doi:10.1186/1745-6215-15-335 · Cited by 165
Kuijpers, H. J. H., van der Heijden, F. M. M. A., Tuinier, S., & Verhoeven, W. M. A. (2007) · Psychopathology · doi:10.1159/000108125 · Cited by 164 · cited 1×
“More serious MRAEs including mania, psychosis, and suicidality have also been reported, often in the contexts of intensive retreats (>5 hrs/day) or in conjunction with pre-existing psychopatholog (Kuijpers et al., 2007; Kuyken et al., 2012; Lindahl et al., 2017; Yorston, 2001).”
Background(2009) · PubMed · Cited by 160
(2018) · Cited by 149
Golomb, B. A., McGraw, J. J., Evans, M. A., & Dimsdale, J. E. (2007) · Drug Safety · doi:10.2165/00002018-200730080-00003 · Cited by 148
Mania precipitated by meditation: a case report and literature review
Yorston, G. A. (2001) · Mental Health, Religion & Culture · doi:10.1080/713685624 · Cited by 138
Unwanted Events and Side Effects in Cognitive Behavior Therapy
Schermuly-Haupt, M.-L., Linden, M., & Rush, A. J. (2018) · Cognitive Therapy and Research · doi:10.1007/s10608-018-9904-y · Cited by 132 · cited 2×
“…questions about AEs in psychotherapy have yielded AE rates of 5–20%, but those rates rise to 40–60% when asked systematically with structured questionnaires about specific experiences (Moritz et al., 2015; Rheker, Beisel, Kraling, & Rief, 2017; Rozental et al., 2019; Schermuly-Haupt et al., 2018).”
BackgroundBritton, W. B., Haynes, P. L., Fridel, K. W., & Bootzin, R. R. (2010) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181dc1bad · Cited by 125 · cited 1×
“In addition, some RCTs have found that average symptom severity significantly worsened in MBP arms compared with control arms (Britton et al., 2010; Johnson et al., 2016; Lomas et al., 2017; Reynolds et al., 2017).”
BackgroundSelf-citationIs mindfulness research methodology improving over time? A systematic review
Goldberg, S. B., Tucker, R. P., Greene, P. A., Simpson, T. L., Kearney, D. J., & Davidson, R. J. (2017) · PLOS ONE · doi:10.1371/journal.pone.0187298 · Cited by 125
Rozental, A., Castonguay, L., Dimidjian, S., Lambert, M., Shafran, R., Andersson, G., & Carlbring, P. (2018) · BJPsych Open · doi:10.1192/bjo.2018.42 · Cited by 124
Lineberry, N., Berlin, J. A., Mansi, B., Glasser, S., Berkwits, M., Klem, C., Bhattacharya, A., Citrome, L., Enck, R., Fletcher, J., et al. (2016) · BMJ · doi:10.1136/bmj.i5078 · Cited by 113
Negative effects of psychotherapies for adult depression: A meta-analysis of deterioration rates
Cuijpers, P., Reijnders, M., Karyotaki, E., de Wit, L., & Ebert, D. D. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.05.050 · Cited by 105
Britton, W. B., Davis, J. H., Loucks, E. B., Peterson, B., Cullen, B. H., Reuter, L., Rando, A., Rahrig, H., Lipsky, J., & Lindahl, J. R. (2018) · Behaviour Research and Therapy · doi:10.1016/j.brat.2017.09.010 · Cited by 100 · cited 6×
“71) as assessed by adapted versions of the MBCT adherence scale (Britton et al., 2018; Segal, Teasdale, Williams, & Gemar, 2002).”
BackgroundMethodInfluentialSelf-citationHauben, M., & Aronson, J. K. (2007) · Drug Safety · doi:10.2165/00002018-200730080-00001 · Cited by 97
Trauma-Sensitive Mindfulness: Practices for Safe and Transformative Healing
Novak, E. T. (2018) · Transactional Analysis Journal · doi:10.1080/03621537.2018.1471295 · Cited by 95
The Safety of Mindfulness-Based Interventions: a Systematic Review of Randomized Controlled Trials
Wong, S. Y. S., Chan, J. Y. C., Zhang, D., Lee, E. K. P., & Tsoi, K. K. F. (2018) · Mindfulness · doi:10.1007/s12671-018-0897-0 · Cited by 92
Introducing a New Intervention: An Overview of Research Phases and Common Challenges
Gitlin, L. N. (2013) · American Journal of Occupational Therapy · doi:10.5014/ajot.2013.006742 · Cited by 90
What is the best evidence for determining harms of medical treatment?
Vandenbroucke, J. P. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.051484 · Cited by 84
The MYRIAD team, Baer, R., Crane, C., Montero-Marin, J., Phillips, A., Taylor, L., Tickell, A., & Kuyken, W. (2021) · Mindfulness · doi:10.1007/s12671-020-01547-8 · Cited by 78
Abramovitch (2015) · doi:10.1016/j.jocrd.2015.02.002 · Cited by 72
The need for expanded monitoring of adverse events in behavioral health clinical trials
Peterson, A. L., Roache, J. D., Raj, J., & Young-McCaughan, S. (2013) · Contemporary Clinical Trials · doi:10.1016/j.cct.2012.10.009 · Cited by 70
Mode Effects in a Survey of Medicare Prostate Surgery Patients
Fowler, Jr., Roman, A. M., & Di, Z. X. (1998) · Public Opinion Quarterly · doi:10.1086/297829 · Cited by 70 · cited 1×
“Thus, because researchers and providers are reliably biased, recent guidelines recommend patient-based reports elicited by an independent party for identifying sensitive or socially undesirable information such as negative reactions to treatment (Dimidjian & Hollon, 2010; Fowler, 1998; Weissman et al., 2008).”
BackgroundLindahl, J. R., Cooper, D. J., Fisher, N. E., Kirmayer, L. J., & Britton, W. B. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.01905 · Cited by 67
Self-citationVaughan, B., Goldstein, M. H., Alikakos, M., Cohen, L. J., & Serby, M. J. (2014) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2014.01.001 · Cited by 63
Harms are assessed inconsistently and reported inadequately part 1: systematic adverse events
Mayo-Wilson, E., Fusco, N., Li, T., Hong, H., Canner, J. K., Dickersin, K., Bertizzolo, L., Cowley, T., Doshi, P., Ehmsen, J., et al. (2019) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2019.04.022 · Cited by 63
Prevalence of harm in mindfulness-based stress reduction
Hirshberg, M. J., Goldberg, S. B., Rosenkranz, M., & Davidson, R. J. (2022) · Psychological Medicine · doi:10.1017/s0033291720002834 · Cited by 62
Horigian, V. E., Robbins, M. S., Dominguez, R., Ucha, J., & Rosa, C. L. (2010) · Clinical Trials · doi:10.1177/1740774509356575 · Cited by 57 · cited 2×
“AE accuracy can be improved by active and systematic monitoring (Horigian et al., 2010), but only if active monitoring scales that assess specific symptoms—which have more sensitive detection rates than either open-ended queries (Allen et al.”
BackgroundMeditation Benefits and Drawbacks: Empirical Codebook and Implications for Teaching
Anderson, T., Suresh, M., & Farb, N. A. (2019) · Journal of Cognitive Enhancement · doi:10.1007/s41465-018-00119-y · Cited by 55 · cited 3×
“, 2018), MBPs may have additional unwanted effects, such as relationship ruptures, dependency, and time burden, that may contribute to dissatisfaction and discontinuation (Anderson et al., 2019).”
BackgroundEliciting adverse effects data from participants in clinical trials
Allen, E. N., Chandler, C. I., Mandimika, N., Leisegang, C., & Barnes, K. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000039.pub2 · Cited by 52
Difficulties in assessing the adverse effects of drugs.
Kramer, M. (1981) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1981.tb01845.x · Cited by 49
Hammad, T. A., Pinheiro, S. P., & Neyarapally, G. A. (2011) · Clinical Trials · doi:10.1177/1740774511419165 · Cited by 46
Parker, G., Fletcher, K., Berk, M., & Paterson, A. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2012.11.026 · Cited by 45
Rate and predictors of negative effects of psychotherapy in psychiatric and psychosomatic inpatients
Rheker, J., Beisel, S., Kräling, S., & Rief, W. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.04.042 · Cited by 44
The FDA and New Safety Warnings
Moore, T. J., Singh, S., & Furberg, C. D. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.618 · Cited by 43
Adverse events of group psychotherapy in the in‐patient setting – results of a naturalistic trial
Schneibel, R., Wilbertz, G., Scholz, C., Becker, M., Brakemeier, E. ‐., Bschor, T., Zobel, I., & Schmoll, D. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12747 · Cited by 43
Cullen, B., Eichel, K., Lindahl, J. R., Rahrig, H., Kini, N., Flahive, J., & Britton, W. B. (2021) · PLOS ONE · doi:10.1371/journal.pone.0244838 · Cited by 43 · cited 5×
“…current study, clinically relevant events associated with impaired functioning occurred within a context of overall efficacy on multiple outcomes (Cullen et al., 2021), high practice compliance and low attrition, which suggest that participants found the difficulties worth tolerating in light of…”
BackgroundMethodInfluentialSelf-citationDevelopment of a Questionnaire for Detecting Potential Adverse Drug Reactions
Corso, D. M., Pucino, F., DeLeo, J. M., Calis, K. A., & Gallelli, J. F. (1992) · Annals of Pharmacotherapy · doi:10.1177/106002809202600704 · Cited by 39
Reynolds, L. M., Bissett, I. P., Porter, D., & Consedine, N. S. (2017) · Mindfulness · doi:10.1007/s12671-017-0705-2 · Cited by 38
The Food and Drug Administration algorithm. Special workshop—regulatory
Turner, W. M. (1984) · Drug Information Journal · doi:10.1177/009286158401800311 · Cited by 37
Chou, R., Fu, R. F., Carson, S., Saha, S. S., & Helfand, M. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.02.021 · Cited by 33
Identifying Risk for Attrition during Treatment for Depression
Warden, D., Trivedi, M. H., Wisniewski, S. R., Lesser, I. M., Mitchell, J. R., Balasubramani, G. K., Fava, M., Shores‐Wilson, K., Stegman, D., & Rush, A. J. (2009) · Psychotherapy and Psychosomatics · doi:10.1159/000235977 · Cited by 33
Challenging and Adverse Meditation Experiences: Toward a Person-Centered Approach
Lindahl, J. R., Britton, W. B., Cooper, D. J., & Kirmayer, L. J. (2019) · The Oxford Handbook of Meditation · doi:10.1093/oxfordhb/9780198808640.013.51 · Cited by 31
Self-citationCharacteristics of adults who used mindfulness meditation: United States, 2012
Morone, N. E., Moore, C. G., & Greco, C. M. (2017) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2016.0099 · Cited by 29
Underestimating harm in mindfulness-based stress reduction
Dam, N. T. V., & Galante, J. (2020) · Psychological Medicine · doi:10.1017/s003329172000447x · Cited by 21
Clinical judgments, not algorithms, are key to patient safety—an essay by David Healy and Dee Mangin
Healy, D., & Mangin, D. A. (2019) · BMJ · doi:10.1136/bmj.l5777 · Cited by 20
Considerations on causality in pharmacovigilance
Edwards, I. R. (2012) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-2012-0552 · Cited by 19
Impact of your results: Beyond the relative risk
Siegerink, B., & Rohmann, J. L. (2018) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12148 · Cited by 19
Prevalence of harm in Mindfulness-Based Stress ReductionPreprint
Hirshberg, M. J., Goldberg, S. B., Rosenkranz, M. A., et al. (2020) · doi:10.31234/osf.io/d26m4 · Cited by 6
Research works printed but not linked: 6
- 10.1037/1040-3590.7.4.424 · doi:10.1037/1040-3590.7.4.424 · Paper page
- Kuyken W., 2012, Mindfulness-Based Cognitive Therapy (MBCT) implementation resources
- Lustyk M., 2009, Advances in Mind-Body Medicine, 24, 20
- Santorelli S., 2017, Mindfulness-Based Stress Reduction (MBSR) authorized curriculum guide
- Talbot J., 2012, Stephens’ detection and evaluation of adverse drug reactions: Principles and practice
- World Health Organization, 2016, The use of the WHO-UMC system for standardized case causality assessment
Cited by
History repeating: guidelines to address common problems in psychedelic science
van Elk, M., & Fried, E. I. (2023) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253231198466 · Cited by 137
“Without such data, we have history repeating all over again, for example, with respect to the adverse effects of mindfulness-based interventions, 68 opioids, 69 or ketamine.”
Prevalence of meditation-related adverse effects in a population-based sample in the United States
Goldberg, S. B., Lam, S. U., Britton, W. B., & Davidson, R. J. (2022) · Psychotherapy Research · doi:10.1080/10503307.2021.1933646 · Cited by 115
Self-citationGalante, J., Friedrich, C., Collaboration of Mindfulness Trials (CoMinT), Aeamla-Or, N., Arts-de Jong, M., Barrett, B., Bögels, S. M., Buitelaar, J. K., Checovich, M. M., Christopher, M. S., et al. (2023) · Nature Mental Health · doi:10.1038/s44220-023-00081-5 · Cited by 113
“There is evidence that some people may not benefit or may even experience harm 74 .”
Palitsky, R., Kaplan, D. M., Peacock, C., Zarrabi, A. J., Maples‐Keller, J. L., Grant, G. H., Dunlop, B. W., & Raison, C. L. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.1554 · Cited by 104
Self-citationA Framework for the Empirical Investigation of Mindfulness Meditative Development
Galante, J., Grabovac, A., Wright, M., Ingram, D. M., Van Dam, N. T., Sanguinetti, J. L., Sparby, T., van Lutterveld, R., & Sacchet, M. D. (2023) · Mindfulness · doi:10.1007/s12671-023-02113-8 · Cited by 84
“However, there are indications that many unwanted effects go underreported unless asked about specifically, which existing trials have not done (Baer et al., 2019; Britton et al., 2021; Hirshberg et al., 2020; Van Dam et al., 2018; Van Dam & Galante, 2020).”
BackgroundResult
Metadata
- Authors
- Britton, W. B., Lindahl, J. R., Cooper, D. J., Canby, N. K., & Palitsky, R.
- Affiliations
- Brown University (US)
- Corresponding author
- Britton, Willoughby B.
- Venue
- Clinical Psychological Science
- Publisher
- SAGE Publications
- Published
- 2021-05-18
- Volume
- 9
- Issue
- 6
- Pages
- 1185-1204
- ISSN
- 2167-7026 (ISSN-L)
- 2167-7034
- PMC
- PMC8845498
- OpenAlex
- W3160994744
- Cited by
- 278
- References
- 105
- Citations by year
- 2026: 55 · 2025: 75 · 2024: 65 · 2023: 50 · 2022: 20 · 2021: 13
- FWCI
- 25.24
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Clinical Psychological Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Center for Complementary and Integrative Health (K23-AT006328-01A1, UH2AT009145)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Social Sciences › Health › Religion, Spirituality, and Psychology
- Keywords
- mindfulness-based cognitive therapy, mindfulness meditation, hyperarousal, dissociation, psychological distress, functioning impairment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.